Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis

Overview of attention for article published in Core Evidence, December 2010

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Increasing Patient Safety Among Multiple Sclerosis (MS) Drug Dalfampridine Users by Expanding Awareness of the Serious Side Effects

Article in Cureus (January 2022)

A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis

Article in Neurología (English Edition) (June 2018)

Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple

Article in Neurología (English Edition) (February 2016)